Dechert LLP is a global specialist law firm focused on sectors with the greatest complexities and highest regulatory demands. Leading global pharmaceutical companies rely on our trial lawyers, appellate lawyers and Ph.D.-level subject matter experts to protect their investment in R&D and take on ANDA challenges with them. Our legal services are distinguished by a high degree of technical and scientific sophistication. Taking an interdisciplinary approach, our strategies are designed to protect and maximize the value of our clients’ pharmaceutical patents. Our deep bench of trial lawyers has extensive experience in the preparation for and litigation of ANDA disputes, and having taken on and won cases involving as many as a dozen ANDA filers, we are not afraid to take these disputes to trial. Likewise, our seasoned antitrust lawyers, which include former FTC personnel, are highly skilled in patent-antitrust and settlement issues.
Dechert’s ability to see the entire ANDA picture from start to finish is a valuable perspective we bring to each Hatch-Waxman Act matter. Our team focuses on our clients’ business needs from the day the Paragraph IV notice is received to the trial and appeal or FTC ANDA settlement review process. When necessary, our team is adept at handling follow-on antitrust litigation.
Our frequent, high-profile success on behalf of life sciences companies means our teams handle highly sensitive matters, including pre-litigation Orange Book reviews and product launch strategic assessments and, in one case, architecting what is likely the largest branded/generic settlement of all time and shepherding it through the FTC.